The Medical Letter on Drugs and Therapeutics
FROM
ISSUE920
ISSUE920
April 15, 1994
Aerosolized Deoxyribonuclease for Cystic Fibrosis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Aerosolized Deoxyribonuclease for Cystic Fibrosis
April 15, 1994 (Issue: 920)
Recombinant human deoxyribonuclease I (rhDNase; dornase alfa; Pulmozyme - Genentech), an enzyme that hydrolyzes extracellular DNA, is now available as a purified solution to decrease the viscosity of sputum in patients with cystic fibrosis. It ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.